CM Conversations is a podcast brought to you by Charlton Morris. We speak to thought leaders from the world of business, as well as the markets we serve. We’re adding content all the time, so if you have a request for a topic or would like to be a guest on CM Conversations to tell your story, get in touch here Contact Us.
In this episode of Diagnostics Digest, I speak with David Wells, Chief Executive Officer of the Institute of Biomedical Science (IBMS) and Chief NHS Pathologist during COVID-19. Click to listen now.
.jpg)
In this episode, I speak to Leigh Fell, CEO at Caritas Neuro Solutions, about carving your niche, the impact of work-life balance, the importance of psychedelic drug discovery and loads more. Click here to listen.
In this episode of Diagnostics Digest, a CM Life Science series discussing trends and insights into the diagnostics market, I speak with Beth Cobb, Chief Operating Officer at NOWDiagnostics | NowDx.
In this episode, I speak with Kirk Sudheimer, SVP of BD & Sales at Health Catalyst about collaboration, innovation and transforming the future of healthcare. Click and have a listen.
In this episode, I chat with Grant Neckermann, SVP of Talent at Syapse, about leading an innovative start-up to success through investment in people. Click to hear his thoughts.
In this episode of Lessons from Leaders in Life Science, I spoke with Jen Skeen, COO at renegade.bio, about carving your own path as a woman in science and so much more. Check out her brilliant story.
In this episode of CM Conversations, I speak with Dr. Callie Seaman, company Director, trained medical professional, and experienced medicinal cannabis advocate about the future of the industry in the UK. Click to have a listen.
First, it's one of Boston's 'Best Small Companies To Work For', then it announced a major Labcorp partnership. But how have Weavr Health overcome the challenges of retaining a core company culture when scaling a fast-growing start-up?
In part two of this discussion, Dennis and I discuss the key barriers for entry for companies expanding into new territories and how to overcome these, whether you're a start-up or established company entering a new market. Click to listen.
In this final part, Dennis and I discuss new technologies to watch in the liquid biopsy market, as well as insights into innovation from behind the scenes at Predicine. Click to listen now.
Apple Podcasts
Spotify
Google
Anchor